Oncology Institute Inc’s recent filing unveils that its Director Hively Brad acquired Company’s shares for reported $42500.0 on Nov 26 ’24. In the deal valued at $0.17 per share,250,000 shares were bought. As a result of this transaction, Hively Brad now holds 616,753 shares worth roughly $0.12 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Hively Brad bought 50,000 shares, generating $7,500 in total proceeds. Upon buying the shares at $0.15, the Director now owns 666,753 shares.
Before that, Havencrest Healthcare Partners sold 8,637 shares. Oncology Institute Inc shares valued at $18,310 were divested by the 10% Owner at a price of $2.12 per share. As a result of the transaction, Havencrest Healthcare Partners now holds 0 shares, worth roughly $0.0.
A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in mid September with a ‘”a Buy”‘ rating. Jefferies began covering TOI with “Buy” recommendation on August 15, 2022.
Price Performance Review of TOI
On Tuesday, Oncology Institute Inc [NASDAQ:TOI] saw its stock fall -3.46% to $0.19. Over the last five days, the stock has lost -13.64%. Oncology Institute Inc shares have fallen nearly -90.69% since the year began. Nevertheless, the stocks have fallen -85.93% over the past one year. While a 52-week high of $2.50 was reached on 01/02/24, a 52-week low of $0.13 was recorded on 11/21/24. SMA at 50 days reached $0.2550, while 200 days put it at $0.6198.
Levels Of Support And Resistance For TOI Stock
The 24-hour chart illustrates a support level at 0.1734, which if violated will result in even more drops to 0.1568. On the upside, there is a resistance level at 0.2038. A further resistance level may holdings at 0.2176. The Relative Strength Index (RSI) on the 14-day chart is 42.75, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0036, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 75.68%. Stochastics %K at 31.67% indicates the stock is a holding.
How much short interest is there in Oncology Institute Inc?
A steep rise in short interest was recorded in Oncology Institute Inc stocks on 2024-10-31, dropping by 4552.0 shares to a total of 0.25 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 0.25 million shares. There was a decline of -1.84%, which implies that there is a negative sentiment for the stock.
